US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 105.430
  • -2.280-2.12%
Close Feb 14 16:00 ET
  • 105.430
  • 0.0000.00%
Post 19:38 ET
208.23BMarket Cap17.96P/E (TTM)

About Novartis AG Company

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Company Profile

SymbolNVS
Company NameNovartis AG
Listing DateMay 11, 2000
Founded1996
CEODr. Vasant Narasimhan
MarketNYSE
Employees75883
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLichtstrasse 35
CityBasel
ProvinceBasel-Stadt (Basle Town)
CountrySwitzerland
Zip Code4056
Phone41-61-324-11-11

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vasant Narasimhan
  • Chief Executive Officer
  • 14.19M
  • Robert Kowalski
  • Chief People and Organization Officer
  • --
  • Dr. Shreeram Aradhye, M.D.
  • President, Development and Chief Medical Officer
  • --
  • Dr. Klaus Moosmayer, PhD
  • Chief Ethics, Risk and Compliance Officer
  • --
  • Harry Kirsch
  • Chief Financial Officer
  • 6.27M
  • Karen L. Hale
  • Chief Legal Officer
  • --
  • Dr. Aharon Gal, PhD
  • Chief Strategy and Growth Officer
  • --
  • Dr. Steffen Lang, PhD
  • President, Operations
  • --
  • Dr. Fiona H. Marshall, PhD
  • President, Biomedical Research
  • --
  • Victor Bulto
  • President, US
  • 5.77M
  • Dr. Patrick Horber, M.D.
  • President, International
  • 5.89M
  • Joerg Reinhardt, PhD
  • Chairman of the Board
  • 3.80M
  • Simon E Moroney, D.Phil.
  • Vice Chairman of the Board
  • 460.00K
  • Ana de Pro Gonzalo
  • Independent Director
  • 390.00K
  • Frans Van Houten
  • Independent Director
  • 390.00K
  • Daniel Hochstrasser
  • Independent Director
  • 394.68K
  • William Thomas Winters
  • Independent Director
  • 360.00K
  • John Douglas Young
  • Independent Director
  • 385.00K
  • Elizabeth Doherty
  • Independent Director
  • 450.00K
  • Bridgette P. Heller
  • Independent Director
  • 430.00K
  • Ton Buechner
  • Independent Director
  • 424.68K
  • Patrice Bula
  • Lead Independent Director
  • 413.78K
  • Dr. Charles L. Sawyers
  • Independent Director
  • 360.00K
  • Dr. Nancy C. Andrews, M.D.,PhD
  • Independent Director
  • 360.00K

Trending Stocks

Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More